Exhibit






Exhibit 10.18
SEPARATION AGREEMENT


This Separation Agreement (the "Agreement") is entered into between Sheldon  Hirt ("Executive" ) and Amneal  Pharmaceuticals, Inc., a Delaware  corporation (the "Company" and, together with Executive, the "Parties" ) and, unless revoked in accordance with Section 5, shall become effective as of the eighth day after the day on which Executive  signs this Agreement (the " Effective Date"), which, for the avoidance of doubt, shall not be prior to the Separation Date (as defined  below).   This Agreement is entered into with reference to the following facts:


		
	A.
	Executive's employment with the Company and status as an officer of the Company and each of its affiliates terminated effective as of January 31, 2019 (the "Separation Date").




		
	B.
	Executive and the Company desire to end their employment relationship amicably and to establish the obligations of the parties including, without limitation, all amounts due and owing to Executive.




In consideration of the mutual covenants and agreements hereinafter set forth, the parties agree as follows:


		
	1. 
	Separation. Executive acknowledges and agrees that his status as an officer and employee of the Company terminated effective as of the Separation Date.  Executive hereby agrees to execute such further document(s) as shall be determined by the Company as necessary or desirable to give effect to the termination of Executive's status as an officer of the Company; provided that such documents shall not be inconsistent with any of the terms of this Agreement.  Additionally, Executive hereby resigns as an officer or director of all of Company’s affiliates or subsidiaries.




2.     Final Paycheck; Expenses.


(a)   Final Paycheck.  On the first  payroll date following the Separation  Date, the Company  shall pay to  Executive  all accrued   but  unpaid  base  salary  and  paid time  off  earned  through  the Separation  Date, less  payroll  deductions and  withholdings.   Executive is entitled to these payments regardless of whether Executive executes this Agreement.


(b)   Business Expenses. Executive agrees that, within five business days after the Separation Date, Executive   will  submit   Executive's  final   documented  expense   reimbursement  statement reflecting all  business  expenses  Executive incurred  through  the Separation Date, if any, for which  Executive  seeks  reimbursement.  The Company will reimburse Executive for these expenses pursuant to its regular business practice.


3.    Separation Payments and Benefits.   Without admission of any liability, fact or claim, the Company hereby agrees to provide the severance benefits below, subject to the execution of this Agreement and Executive's performance of his continuing obligations pursuant to this Agreement and that certain Employee Confidentiality, Non-Solicitation, and Ownership of Inventions Agreement entered into between the Executive and Amneal Pharma LLC as of September 13, 2016 (the "Confidentiality Agreement").


(a)   Cash Severance.  The  Company  shall  pay, or shall  call  its affiliate  employing Executive  to pay, to Executive  a cash payment  equal to $693,450.00, which represents  (x) Executive's annual base salary  as  in effect  immediately prior  to the  Separation Date,  plus (y)  Executive’s  target annual  bonus in 


1







the amount of fifty percent of Executive’s annual base salary, plus (z) $60,000.00, such payment  to be made as soon as administratively possible after the Effective  Date.
(b)  Equity Awards. As of the Separation Date, Executive holds 17,766 Company restricted stock units (the "RSUs" ) and an option (the "Option") to purchase an aggregate of 72,661  shares of Company   common   stock,  each  of  which  is  unvested  as  of  the  Separation   Date  and,  in accordance with their terms, shall automatically terminate on the Separation  Date for no consideration.


(c)  Continued Benefits Healthcare Continuation Coverage.  If Executive  is eligible for and timely elects to receive continued healthcare coverage  pursuant to the provisions  of the Consolidated Omnibus   Budget  Reconciliation Act  of  1985,  as  amended  ("COBRA"), the  Company  will partially  subsidize, or  cause  its  affiliate   employing  Executive   to  partially  subsidize, the premium  cost for continued  group  medical,  dental, and/or vision coverage  during  the period commencing on the Separation Date and ending  on the earliest  of (i) January  31 , 2020, (ii) the expiration  of Executive 's (or Executive 's legal dependent's, as applicable) eligibility for benefits  under COBRA,  and (iii) such time as Executive  becomes eligible  to receive  medical benefits   under  a  "group  health  plan"  (within  the  meaning  of  COBRA)   maintained   by  a subsequent employer of Executive (provided  that Executive  is eligible to continue  Executive's COBRA coverages by paying the full cost of the applicable COBRA  premiums after eligibility for such other  group  health  plan until such COBRA  coverage is otherwise terminated) (such period, the "COBRA Period”), in each case, for Executive  and Executive 's legal dependents who are participating in such coverages as of Executive's termination  of employment. During the COBRA  Period, (1) Executive  will  pay the same  amount  toward  the  premium  cost  for Executive  and  Executive 's dependents'  medical  and dental  coverage  that  he would  pay for that same  level of coverage  as an active employee, and the Company  will pay, or cause to be  paid  the  balance  of  the  premium  cost,  and  (2)  Executive   will  pay the  full  cost  of  the premium  for vision  coverage  and the Company  will  pay, or cause  to be paid, the applicable two percent (2%) COBRA  administrative fee; provided , however, that (A) if any plan pursuant to which  such  benefits  are provided  is not, or ceases  prior to the expiration  of the  period of continuation coverage to  be, exempt  from  the  application of  Section  409A  of  the  Internal Revenue Code of 1986, as amended  (the "Code" ), under Treasury  Regulation  Section  1.409 A­I (a)(S)  or  (B)  the  Company, or  its  affiliate  employing  Executive,  is otherwise unable  to continue  to  cover   Executive   under   its  group   health   plans   without   incurring   penalties (including, without  limitation, pursuant  to the Patient  Protection  and Affordable Care  Act or Section  2716  of the  Public  Health  Service  Act), then , in either  case, an amount  equal  to the premium  contribution amount  that  would  have  been  paid  by the  Company, or  its affiliate employing Executive, for each  remaining  COBRA  premium  under such  plans shall thereafter be  paid  to  Executive  in  substantially  equal   monthly   installments  over  the  continuation coverage   period  (or  the  remaining portion  thereof). After  the  Company ceases  to  pay  or reimburse premiums  pursuant  to the preceding  sentence, Executive  may,  if eligible,  elect to continue healthcare coverage at  Executive 's expense  in accordance with  the  provisions  of COBRA.   Executive  acknowledges that he shall  be solely  responsible for all matters  relating to Executive's continuation of coverage  pursuant  to COBRA,  including, without  limitation, Executive 's election  of such coverage and his timely  payment  of premiums.


(d)  Outplacement.    Executive   shall   be eligible   to receive   outplacement  and  career   services counseling for  up to 26  weeks  following the Separation Date from Lee Hecht Harrison or another nationally-recognized outplacement firm engaged by the Company for similarly-situated executives.




2







(e)   Withholdings and Deductions.  All compensation payable to Executive under this Agreement shall be made less applicable withholdings and deductions.


(f)   Sole Separation Benefit.  Executive  agrees  that the payments  provided  by this Section  3 are not  required   under  the  Company's  normal  policies  and  procedures and  are  provided  as  a severance solely in connection  with this Agreement.


		
	4. 
	Full Payment. Executive acknowledges that the payment and arrangements herein shall constitute full and  complete  satisfaction  of any and all amounts  properly  due and owing  to Executive  as a result of his employment with the Company and the termination  thereof.    Executive further acknowledges that this Agreement shall supersede each agreement entered into between Executive and the Company regarding Executive's employment other than the Confidentiality Agreement. Except  to the extent  provided  in Section  6, each  such agreement, or portion  thereof,  superseded hereby shall  be deemed  terminated  and of no further effect as of the Separation  Date.




		
	5. 
	Executive's Release of the Company.   Executive  understands that  by agreeing to  the  release provided  by this Section  5, Executive is agreeing not to sue, or otherwise file any claim against, the Company   or  any  of  its directors, officers,  employees, investors  or  other  agents  for  any  reason whatsoever based on anything  that has occurred  as of the date Executive  signs this Agreement.




(a) General Release. On behalf of Executive and Executive's heirs, assigns, executors, administrators, trusts, spouse  and estate, Executive  hereby releases  and forever  discharges the "Releasees"   hereunder, consisting of the Company and each of its owners, affiliates, subsidiaries, predecessors, successors, assigns, agents, directors, officers,  partners, employees, and insurers, and all persons acting by, through,  under or in concert  with them, or any of them, of and from  any and all  manner  of action  or actions,  cause  or causes  of action,  in law or in equity, suits,   debts,   liens,   contracts,  agreements,  promises,    liability,   claims,   demands, damages,  loss,  cost  or  expense, of  any  nature  whatsoever,  known  or  unknown ,  fixed  or contingent (hereinafter called "Claims" ), which  Executive  now  has or  may  hereafter  have against  the  Releasees, or any of them,  by reason  of any  matter,  cause,  or thing  whatsoever from the beginning of time to the date hereof, including,  without  limiting  the generality  of the foregoing, any Claims arising out of, based upon , or relating to Executive 's hire, employment, remuneration or termination by the Releasees, or any of them, Claims  arising  under federal , state,  or local  laws relating  to employment, Claims  of any  kind that  may  be brought  in any court or administrative agency,  including any Claims arising  under the Age Discrimination in Employment Act ("ADEA" ), 29 U.S.C. § 621 , et seq., the Older  Workers  Benefit  Protection Act of 1990; the Title VII of the Civil  Rights Act of 1964, as amended , 42 U.S.C. §  2000, et seq.;   Americans  with   Disabilities  Act,   as   amended ,  42 U .S.C.   § 12101   et   seq.;   the Rehabilitation Act of 1973, as amended, 29 U.S.C.  § 701  et seq.;  Civil  Rights  Act of 1866, and Civil Rights Act of 1991 ; 42 U .S.C. § 1981 , et seq.; Equal Pay Act, as amended,  29 U .S.C. § 206(d); regulations of the Office of Federal Contract  Compliance, 41 C.F.R.  Section  60, et seq.; the Family and Medical Leave Act, as amended,  29 U.S.C. § 260 I   et seq.; the Fair Labor Standards Act of 1938, as amended , 29 U.S.C. § 201 et seq.; the Employee Retirement Income Security Act, as amended , 29 U .S.C.  § I 00 I   et seq.; the Worker Adjustment and Retraining Notification Act, as amended, 29 U .S.C.  § 210 I  et seq.; the Fair Credit  Reporting Act and all similar  state laws regarding background checks;  the New Jersey  Law Against  Discrimination; the New Jersey  Conscientious Employee Protection  Act; the New Jersey  Family  Leave Act; the New Jersey  Wage  Payment  Law; the New Jersey  Wage and  Hour  Law; the New Jersey Equal Pay Act; retaliation  Claims  under the New Jersey Workers' Compensation Law; Claims 


3







for breach of contract;  Claims arising in tort, including, without  limitation , Claims of wrongful dismissal   or  discharge,  discrimination ,  harassment,  retaliation ,  fraud,   misrepresentation, defamation , libel , infliction  of emotional distress, violation  of public policy, and/or  breach of the implied covenant  of good faith and fair dealing; and Claims for damages  or other remedies of any sort, including, without limitation, compensatory damages, punitive damages, injunctive relief and attorney 's fees.


(b)  Unreleased Claims. Notwithstanding the generality of the foregoing, Executive does not release the following claims:


(i)    Claims for unemployment compensation or any state disability insurance benefits pursuant to the terms of applicable state law;


(ii)   Claims for workers' compensation insurance benefits under the terms of any worker's compensation insurance policy or fund of the Company;


(iii)  Claims to continued participation in certain of the Company's group benefit plans pursuant to the terms and conditions of COBRA;


(iv)  Claims to any benefit entitlements vested as the date of Executive's employment termination, pursuant to written terms of any Company employee benefit plan;


(v)   Claims for indemnification under the Company's Bylaws, Certificate of Incorporation, and/or any applicable indemnification polic(ies) or indemnification agreement;


(vi)  Executive's right to bring to the attention of the Equal Employment Opportunity Commission claims of discrimination; provided , however, that Executive does release Executive's right to secure any damages for alleged discriminatory treatment; and


(vii) Claims relating to Company 's obligations pursuant to this Agreement.




(c)   Older Workers Benefit Protection Act. In accordance with the Older Workers Benefit Protection Act, 
Executive is hereby advised as follows:


(i)     Executive has read this Agreement and understands its terms and effect.


(ii)   Executive understands that, by entering into this Agreement, Executive does not waive any Claims that may arise after the date Executive signs this Agreement.


(iii)  Executive has signed this Agreement voluntarily and knowingly in exchange for the consideration described in this Agreement, which Executive acknowledges is adequate and satisfactory to Executive and in addition to any other benefits to which Executive is otherwise entitled.


(iv)  The Company advises Executive to consult with an attorney before executing this Agreement.






4







(v)  Executive has 21 days to review and decide whether or not to sign this Agreement.  If Executive signs this Agreement before the expiration of such period, Executive acknowledges that Executive has done so voluntarily, had sufficient time to consider  the Agreement, to consult with counsel and that Executive does not desire additional time and hereby waives the remainder of the 21-day period.  In the event of any changes to this Agreement, whether or not material, Executive waives the restarting of the 21-day period .


(vi)  Executive has seven days after signing this Agreement to revoke this Agreement and this Agreement will become effective upon the expiration of that revocation period. If Executive revokes this Agreement during such seven-day period, this Agreement will be null and void and of no force or effect on either the Company or Executive and Executive will not be entitled to any of the payments or benefits which are expressly conditioned upon the execution and non-revocation of this Agreement.


If Executive wishes to revoke this Agreement, Executive must deliver written notice of Executive's revocation to Michelle Foster at 400 Crossing Blvd, 3rd Floor, Bridgewater, New Jersey 08807, on or before 5:00 p.m. on the seventh day after the date on which Executive signs this Agreement.


6.  Continuing Obligations.  Executive acknowledges Executive's continuing obligations under the Confidentiality Agreement, which shall be deemed incorporated herein by reference.  The Confidentiality Agreement shall remain in full force and effect for the periods set forth therein.


		
	7. 
	Executive Representations.  Executive warrants and represents that (a) he has not filed or authorized the filing of any complaints, charges  or lawsuits  against  the Company, or any affiliate of the Company  with  any governmental agency  or court,  and that  if, unbeknownst to Executive, such a complaint, charge or lawsuit has been filed on his behalf, he will immediately cause it to be withdrawn and dismissed, (b) he has reported all hours worked as of the date of this  Agreement and  has been paid all compensation, wages, bonuses, commissions, and/or benefits to which he may be entitled and no other compensation, wages, bonuses, commissions and/or benefits are due to him, except as provided in this Agreement, (c) he has no known workplace injuries or occupational diseases and has been provided and/or has not been denied any leave requested under the Family and Medical Leave Act or any similar state law, (d) the execution, delivery and performance of this Agreement by Executive does not and will not conflict with, breach, violate or cause a default under any agreement, contract or instrument to which Executive is a party or an y judgment, order or decree to which Executive is subject, and (e) upon the execution and delivery of this Agreement by the Company and Executive, this Agreement will be a valid and binding obligation of Executive, enforceable in accordance with its terms.




8.   No Assignment by Executive.   Executive warrants and represents that no portion of any of the matters released herein, and no portion of any recovery or settlement to which Executive might be entitled, has been assigned or transferred to any other person, firm or corporation not a party to this Agreement, in any  manner, including by way of subrogation or operation of law or otherwise.  If any claim, action, demand or suit should be made or instituted against the Company or any other Releasee because of any actual assignment, subrogation or transfer by Executive, Executive agrees to indemnify and hold harmless the Company and all other Releasees against such claim, action, suit or demand, including necessary expenses of investigation, attorneys' fees and costs.  In the event of Executive's death, this Agreement shall inure to the benefit of Executive and Executive's executors, administrators, heirs, distributees, devisees, and legatees.  None of Executive's rights or obligations may be assigned or transferred by Executive, other than Executive's rights to payments hereunder, which may be transferred only upon Executive's death by will or operation of law.


5









		
	9. 
	Arbitration.   Any controversy, claim or dispute arising out of or relating to this Agreement, shall be settled solely and exclusively by a binding arbitration process administered by JAMS in Somerset County, New Jersey.  Such arbitration shall be conducted in accordance with the then­existing JAMS Rules of Practice and Procedure, before a sole arbitrator pursuant to its Streamlined Arbitration Rules and Procedures.  The rules can be found at www.jamsadr.com/adr-rules­procedures/, or a copy will be provided upon request.  The arbitrator shall: (i) provide adequate discovery for the resolution of the dispute; and (ii) issue a written arbitration decision, to include the arbitrator's essential findings and conclusions and a statement of the award.  Except to the extent of filing fees Executive would incur were the matter to be litigated in court, the Company shall be responsible for the JAMS administrative fees and the arbitrator's fees and costs.  The arbitrator shall award the prevailing Party attorneys' fees and expert fees, if any.  The Parties agree to abide by all decisions and awards rendered in such proceedings.   Such decisions and awards rendered by the arbitrator shall be final and conclusive.  All such controversies, claims or disputes shall be settled in this manner in lieu of any action at law or equity; provided, however, that nothing in this subsection shall be construed as precluding the bringing of an action for injunctive relief or specific performance as provided in this Agreement or the Confidentiality Agreement. This dispute resolution  process and any arbitration  hereunder  shall be confidential  and neither any Party nor the neutral  arbitrator shall disclose  the existence, contents  or results of such process without the prior written  consent  of  all  Parties,  except  where  necessary  or  compelled   in a court  to  enforce  this arbitration  provision or an award from such arbitration or otherwise  in a legal proceeding. Executive  and the Company  understand  that by agreement  to arbitrate  any claim  pursuant  to this Section  9, they  will  not have the  right to have any claim  decided  by a jury  or a court,  but shall instead  have  any  claim  decided   through  arbitration.  Executive and the Company waive any constitutional or other right to bring claims covered by this Agreement other than in their individual capacities. Except as may be prohibited by applicable law, the foregoing waiver includes the ability to assert claims as a plaintiff or class member in any purported class or representative proceeding.




10.  Governing Law.   This Agreement shall be construed and enforced in accordance with, and the rights of the parties shall be governed by, the laws of the state of New Jersey or, where applicable, United States federal law, in each case, without regard to any conflicts of laws provisions or those of any state other than New Jersey.


		
	11.
	Miscellaneous.  This Agreement, collectively with the Confidentiality Agreement, constitutes the entire agreement between the parties with regard to the subject matter hereof and supersedes, in their entirety, any other  agreements between Executive and the Company with regard to the  subject matter hereof.   Executive acknowledges that there are no other agreements, written, oral or implied, and that he may not rely on any prior negotiations, discussions, representations or agreements. This Agreement may be modified only in writing, and such writing must be signed by Executive and a duly authorized officer of the Company or member of the Company’s Board of Directors and recited that it is intended to modify this Agreement. This Agreement may be executed in separate counterparts, each of which is deemed to be an original and all of which taken together constitute one and the same agreement.




		
	12.
	Company Assignment and Successors. The Company shall assign its rights and obligations under this  Agreement to any  successor to  all  or substantially all  of the  business  or  the  assets  of the Company (by merger or otherwise). This Agreement shall be binding upon and inure to the benefit of the Company and its successors, assigns, personnel and legal representatives.






6







13. Maintaining Confidential Information.  Executive reaffirms his obligations under the Confidentiality Agreement.  For the avoidance of doubt, nothing  in the Confidentiality Agreement or this  Agreement will  be construed to prohibit Executive from filing a charge with, reporting possible violations to, or participating or cooperating with  any  governmental agency or entity, including but not limited to the EEOC, the Department of Justice, the Securities and  Exchange Commission, Congress, or  any  agency  Inspector  General, or making other disclosures that are protected under the whistleblower, anti-discrimination, or anti-retaliation  provisions of federal, state or local law or regulation.  Executive does not need the prior authorization of the Company to make any such reports or disclosures, and Executive is not required to notify the Company that he has made such reports or disclosures.  Furthermore, in accordance with 18 U .S.C. § 1833, notwithstanding anything to the contrary  in the Confidentiality Agreement or this Agreement: (i) Executive  shall not be in breach of this Agreement, and shall not be held criminally  or civilly  liable under any federal  or state trade secret  law (x) for the disclosure of a trade secret  that  is made  in confidence to a federal,  state, or local government official  or to an attorney  solely for the purpose of reporting  or investigating a suspected  violation  of law, or (y) for the disclosure  of a trade secret that is made in a complaint or other document  filed  in a lawsuit  or other  proceeding, if such filing is made under seal ; and (ii) if Executive  files a lawsuit for retaliation  by the Company  for reporting a suspected  violation  of law, Executive  may disclose  the trade secret to Executive's attorney, and may  use the  trade  secret  information   in the  court  proceeding, if  Executive  files  any  document containing the trade  secret  under seal, and does  not disclose  the trade  secret,  except  pursuant  to court order.


14.  Executive's Cooperation.  After the Separation Date, upon written request, Executive shall cooperate with the Company and its affiliates, upon the Company's reasonable request, with respect to any internal  investigation or  administrative,  regulatory   or  judicial   proceeding  involving   matters   within   the  scope   of Executive 's duties and responsibilities to the Company  or its affiliates  during his employment with the  Company   (including, without   limitation ,  Executive   being  available   to  the  Company   upon reasonable notice for interviews  and factual  investigations, appearing at the Company's reasonable request to give testimony  without  requiring service of a subpoena or other legal process, and turning over  to  the  Company  all  relevant   Company  documents  which   are  or  may  have  come   into Executive 's possession during  his employment); provided , however, that an y such  request  by the Company  shall not be unduly burdensome or interfere with Executive's personal schedule or ability to engage  in gainful  employment.  The Company agrees to reimburse Executive for his reasonable expenses in participating in the prosecution or defense of any investigation, litigation, arbitration or administrative proceeding as well as to reimburse Executive for any lost income resulting from compliance with the obligations of this paragraph, provided that Executive submits acceptable documentation of all such expenses and lost income.


15.   Section 409A of the Code.  The Company and Executive acknowledge that the separation  of the Executive 's employment with the Company  is intended to constitute an involuntary separation  from service  for  the  purposes  of Section  409A  of the  Code,  and  the  related  Department of Treasury regulations and other interpretative guidance  issued thereunder ("Section 409A" ). This Agreement is intended,  to the  greatest  extent  permitted  under  law,  to comply  with  the  short-term deferral exemption and the separation   pay exemption provided  in Section  409A  such  that  no benefits  or payments  under this Agreement are subject  to Section  409A.   Notwithstanding anything herein to the contrary, the timing of any payments under this Agreement shall be made consistent with such exemption. To the extent applicable, this Agreement shall be interpreted in accordance with Section 409A, including without limitation any such regulations or other guidance that may be issued after the Separation Date.  Notwithstanding any provision  of this Agreement  to the contrary, in the event that the Company determines that any amounts payable hereunder  may be subject  to Section  409A, the Company  may, to the extent  permitted  under Section 409A cooperate 


7







in good faith to adopt such amendments to this Agreement or adopt other appropriate policies  and procedures, including amendments and  policies  with  retroactive effect,  that  the Company  determines are  necessary  or appropriate to  avoid  the  imposition   of  taxes  under  Section  409A;  provided,  however,  that  this paragraph  shall not create  an obligation  on the part of the Company to adopt any such amendment, policy  or  procedure or take  any such  other  action,  nor shall  the Company  have  any  liability for failing  to do so.   To the extent  that any  reimbursements payable  pursuant  to this  Agreement are subject to the provisions of Section  409 A, such reimbursements shall be paid to Executive no later than December  31 of the year following the year in which the expense was incurred, the amount  of expenses reimbursed in one year shall not affect the amount  eligible  for reimbursement in any subsequent year, and Executive's right to reimbursement under this Agreement will not be subject to liquidation  or exchange for another  benefit.


16.  No Disparagement and Neutral Reference.  If Company personnel are contacted regarding prospective employment inquiries to the Company, they will not disparage Executive in any manner and shall provide a neutral or positive reference consistent with the Company’s general reference policy to any such prospective employer. Executive shall not disparage any Company executive, officer or director.


17.   Confidentiality of this Agreement.  Executive and the Company agree that, at all times, the existence, terms and conditions of this Agreement will be kept secret and confidential and will not be disclosed voluntarily to any third party, except:  (a) to Executive’s spouse, domestic partner or immediate family member; (b) to the extent required by law, including any requirement to publicly file this Agreement with the United States Securities and Exchange Commission; (c) in connection with any claim to enforce, interpret or determine the scope, meaning, enforceability or effect of the Agreement as for which the parties will take any and all steps reasonable necessary to insure confidentiality of the Agreement as part of such proceedings; or (d) to obtain confidential legal, tax or financial advice with respect thereto.


Notwithstanding the foregoing, this Agreement is not intended to restrict or otherwise interfere 
with the parties’ obligation to testify truthfully in any forum or to restrict or otherwise interfere 
with their right and/or obligation to contact, cooperate with or provide information to any 
government agency or commission.


(signature page follows)


8













The  undersigned   have  signed  this  Separation   Agreement  on  the  dates  indicated  next  to their  respective signatures.


	
		
	Dated: February 5, 2019
	EXECUTIVE

	 
	/s/ Sheldon Hirt

	 
	Sheldon Hirt

	 
	 

	Dated: February 5, 2019
	AMNEAL PHARMACEUTICALS, INC.

	 
	/s/ Robert Stewart

	 
	By: Robert Stewart

	 
	Its: President and Chief Executive Officer








9